SCHEMBL23032086

SCHEMBL23032086

N=N/C(=C\NCCF)COCc1ccc(Br)cc1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.32
▸ AGER Q15109 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23031999 0.84 RAB9A (0.34) IDO1
SCHEMBL23032000 0.80 KDM4E (0.30) —
SCHEMBL23031763 0.80 IDO1 (0.38) IDO1AGER
SCHEMBL23031761 0.78 IDO1 (0.36) IDO1AGER
SCHEMBL23031868 0.76 IDO1 (0.42) IDO1AGER
SCHEMBL23032002 0.72 AGER (0.36) IDO1AGER
SCHEMBL23032087 0.64 LOXL2 (0.38) IDO1
SCHEMBL30984440 0.64 RXRA (0.42) IDO1
SCHEMBL10458623 0.63 IDO1 (0.50) IDO1
SCHEMBL649020 0.62 IDO1 (0.64) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021034924-A1 TRANS-CYCLOOCTENE LABELED ANTISENSE OLIGONUCLEOTIDES, RADIO LABELED TETRAZINE AND METHODS BIOGEN MA INC. (US) 2021-02-25 — — WO disclosed
Send feedback